Get the app!
Back to Trades
Sell4

THERMO FISHER SCIENTIFIC INC.

TMO

Total Value
$4.5M
Net $2.1M sold
Sales
$2.1M
13 transactions

Company Information

Ticker Symbol
TMO
CIK
0000097745

Insider Information

Role
Chairman & CEO, Director
DirectorOfficer
Location
WALTHAM, MA

Filing Details

Filing Date
Mar 9, 2026
Transaction Date
Mar 5, 2026
Accession Number
0000097745-26-000058
Form Type
4
Net Trading Amount
-$2.1M

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Mar 5, 2026Common Stock4,000$309.63Exercise$1.2M
Mar 5, 2026Common Stock20$503.66Sale$10.1K
Mar 5, 2026Common Stock60$505.76Sale$30.3K
Mar 5, 2026Common Stock58$507.54Sale$29.4K
Mar 5, 2026Common Stock99$509.66Sale$50.5K
Mar 5, 2026Common Stock214$511.78Sale$109.5K
Mar 5, 2026Common Stock411$512.73Sale$210.7K
Mar 5, 2026Common Stock1,133$513.71Sale$582.0K
Mar 5, 2026Common Stock570$514.71Sale$293.4K
Mar 5, 2026Common Stock348$515.64Sale$179.4K
Mar 5, 2026Common Stock201$516.73Sale$103.9K
Mar 5, 2026Common Stock106$517.83Sale$54.9K
Mar 5, 2026Common Stock516$519.13Sale$267.9K
Mar 5, 2026Common Stock264$519.74Sale$137.2K

Derivative Transactions

DateSecuritySharesExercise PriceTypeValue
Mar 5, 2026Derivative4,000$309.63Exercise$1.2M

Footnotes

  1. (F1)The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2025.
  2. (F2)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $505.36 to $506.16, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12) and (13) to this Form 4.
  3. (F3)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $507.40 to $508.12, inclusive.
  4. (F4)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $509.63 to $509.76, inclusive.
  5. (F5)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $511.21 to $512.18, inclusive.
  6. (F6)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $512.23 to $513.22, inclusive.
  7. (F7)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $513.27 to $514.24, inclusive.
  8. (F8)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $514.28 to $515.24, inclusive.
  9. (F9)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $515.30 to $516.00, inclusive.
  10. (F10)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $516.47 to $517.07, inclusive.
  11. (F11)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $517.60 to $518.16, inclusive.
  12. (F12)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $518.62 to $519.57, inclusive.
  13. (F13)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $519.62 to $519.91, inclusive.
  14. (F14)The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
  15. (F15)The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
  16. (F16)The option vested in four equal installments on February 25, 2021, 2022, 2023, and 2024.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.